707 related articles for article (PubMed ID: 16340083)
1. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
Rivera EJ; Goldin A; Fulmer N; Tavares R; Wands JR; de la Monte SM
J Alzheimers Dis; 2005 Dec; 8(3):247-68. PubMed ID: 16340083
[TBL] [Abstract][Full Text] [Related]
2. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM
J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215
[TBL] [Abstract][Full Text] [Related]
3. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
Moroz N; Tong M; Longato L; Xu H; de la Monte SM
J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
Lester-Coll N; Rivera EJ; Soscia SJ; Doiron K; Wands JR; de la Monte SM
J Alzheimers Dis; 2006 Mar; 9(1):13-33. PubMed ID: 16627931
[TBL] [Abstract][Full Text] [Related]
5. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
de la Monte SM
Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
[TBL] [Abstract][Full Text] [Related]
6. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.
de la Monte SM; Wands JR
J Alzheimers Dis; 2006 Jul; 9(2):167-81. PubMed ID: 16873964
[TBL] [Abstract][Full Text] [Related]
7. si-RNA inhibition of brain insulin or insulin-like growth factor receptors causes developmental cerebellar abnormalities: relevance to fetal alcohol spectrum disorder.
de la Monte SM; Tong M; Bowling N; Moskal P
Mol Brain; 2011 Mar; 4():13. PubMed ID: 21443795
[TBL] [Abstract][Full Text] [Related]
8. Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.
Tong M; Dong M; de la Monte SM
J Alzheimers Dis; 2009; 16(3):585-99. PubMed ID: 19276553
[TBL] [Abstract][Full Text] [Related]
9. Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model.
Cohen AC; Tong M; Wands JR; de la Monte SM
Alcohol Clin Exp Res; 2007 Sep; 31(9):1558-73. PubMed ID: 17645580
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.
de la Monte SM; Tong M; Lester-Coll N; Plater M; Wands JR
J Alzheimers Dis; 2006 Sep; 10(1):89-109. PubMed ID: 16988486
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.
de la Monte SM; Tong M
J Alzheimers Dis; 2009; 17(4):817-25. PubMed ID: 19542621
[TBL] [Abstract][Full Text] [Related]
12. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
Zhang B; Tang XC; Zhang HY
J Neurosci Res; 2013 May; 91(5):717-25. PubMed ID: 23401344
[TBL] [Abstract][Full Text] [Related]
13. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.
de la Monte SM; Wands JR
J Alzheimers Dis; 2005 Feb; 7(1):45-61. PubMed ID: 15750214
[TBL] [Abstract][Full Text] [Related]
14. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
de la Monte SM; Tong M; Schiano I; Didsbury J
J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
[TBL] [Abstract][Full Text] [Related]
15. Disturbed cross talk between insulin-like growth factor I and AMP-activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein/presenilin 2 mouse model of Alzheimer's disease.
Lopez-Lopez C; Dietrich MO; Metzger F; Loetscher H; Torres-Aleman I
J Neurosci; 2007 Jan; 27(4):824-31. PubMed ID: 17251422
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer-associated neuronal thread protein mediated cell death is linked to impaired insulin signaling.
de la Monte SM; Wands JR
J Alzheimers Dis; 2004 Jun; 6(3):231-42. PubMed ID: 15201478
[TBL] [Abstract][Full Text] [Related]
17. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.
O'Neill C; Kiely AP; Coakley MF; Manning S; Long-Smith CM
Biochem Soc Trans; 2012 Aug; 40(4):721-7. PubMed ID: 22817723
[TBL] [Abstract][Full Text] [Related]
18. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
Keeney JT; Ibrahimi S; Zhao L
J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
[TBL] [Abstract][Full Text] [Related]
19. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
20. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
Zemva J; Schubert M
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
